跳至主要内容
临床试验/JPRN-UMIN000021844
JPRN-UMIN000021844招募中4 期

Innovative endovascular treatment strategy by angiography, IVUS and pressure gradient guidance in SFA disease with a new nitinol stent system -A prospective multicenter study- - IGNITE study

Japan Endovascular Treatment Conference0 个研究点目标入组 300 人开始时间: 2016年4月9日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Acute critical limb ischemia 2) Severe critical limb ischemia (Rutherford category 6) 3) Known hypersensitivity or contraindication to any of the following medications: heparin, aspirin, clopidogrel 4) Age < 20 years 5) Life expectancy <2 year due to comorbidity 6) Severe dementia or bedridden case Angiographic criteria 1) Target lesion length > 150 mm by angiographic estimation (TASC II C and D lesion) 2) Previous bypass surgery or stenting of the superficial femoral artery 3) Diseased CFA or distal popliteal artery (P2 or P3 segment) with stenosis more than 50%)

研究者

发起方
Japan Endovascular Treatment Conference

相似试验